Summary
Aequus Pharmaceuticals Inc (Aequus) is a healthcare company that develops and commercializes differentiated drugs. The company’s pipeline products include AQS301, AQS302, AQS303; and its commercial pipeline includes transplant product and ophthalmology product. It develops products in the areas of neurology and psychiatry with addressing the need for improved medication through enhanced delivery systems. Aequus concentrates on hospital specialty markets in Canada, including patented products, branded generics, and reformulated novel-delivery products within focused therapeutic areas. The company provides products for the therapeutic areas including neurology, ophthalmology and transplant. Aequus is headquartered in Vancouver, British Columbia, Canada.
Aequus Pharmaceuticals Inc (AQS) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Aequus Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Aequus Pharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Aequus Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Aequus Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Aequus Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Aequus Pharmaceuticals Inc, Medical Equipment, Deal Details 10
Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 10
Equity Offering 10
Aequus Pharma Raises USD3.9 Million in Public Offering of Units 10
Aequus Pharma Raises USD2 Million in Public Offering of Shares 11
Aequus Pharma Raises USD1.3 Million in Public Offering of Shares 13
Aequus Pharma Raises USD0.6 Million in Private Placement of Shares 14
Aequus Pharmaceuticals Inc - Key Competitors 16
Key Employees 17
Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Nov 30, 2016: Aequus Provides Q3 2016 Financial Highlights With Substantial Increase in Quarter Over Quarter Revenues 19
Corporate Communications 20
Jul 22, 2016: Aequus Appoints Ann Fehr as Chief Financial Officer 20
Other Significant Developments 21
Aug 30, 2016: Aequus Provides Corporate Update on Commercial and Development Programs 21
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24
List of Tables
Aequus Pharmaceuticals Inc, Medical Equipment, Key Facts, 2015 1
Aequus Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Aequus Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Aequus Pharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Aequus Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Aequus Pharmaceuticals Inc, Deals By Market, 2011 to YTD 2017 8
Aequus Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 10
Aequus Pharma Raises USD3.9 Million in Public Offering of Units 10
Aequus Pharma Raises USD2 Million in Public Offering of Shares 11
Aequus Pharma Raises USD1.3 Million in Public Offering of Shares 13
Aequus Pharma Raises USD0.6 Million in Private Placement of Shares 14
Aequus Pharmaceuticals Inc, Key Competitors 16
Aequus Pharmaceuticals Inc, Key Employees 17
Aequus Pharmaceuticals Inc, Subsidiaries 18
List of Figures
Aequus Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Aequus Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Aequus Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Aequus Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Aequus Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Aequus Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
Aequus Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Aequus Pharmaceuticals Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8